Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck

Annals of Oncology

Volumn 25, Issue 10, 2014, Pages 2042-2047

  Tinhofer, I ^a   Konschak, R ^a,b   Stromberger, C ^a   Raguse, J D ^a   Dreyer, J H ^c   Johrens K ^a   Keilholz, U ^a   Budach, V ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNFALLKRANKENHAUS BERLIN   (Germany)

Author keywords

adjuvant treatment; biomarker; chemoradiation; circulating tumor cells; HPV associated carcinoma

Indexed keywords

TUMOR MARKER;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; BLOOD; DISEASE FREE SURVIVAL; DRUG EFFECTS; EPITHELIUM CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; RADIATION RESPONSE; SQUAMOUS CELL CARCINOMA; TUMOR EMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; EPITHELIAL CELLS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 84930654921     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu271     Document Type: Article

References (21)

1. Licitra, L., Perrone, F., Bossi, P., et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24 (2006), 5630–5636.
2. Cristofanilli, M., Budd, G.T., Ellis, M.J., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351 (2004), 781–791.
3. Cohen, S.J., Punt, C.J., Iannotti, N., et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26 (2008), 3213–3221.
4. Scher, H.I., Jia, X., de Bono, J.S., et al. Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data. Lancet Oncol 10 (2009), 233–239.
5. Brakenhoff, R.H., Stroomer, J.G., ten Brink, C., et al. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Clin Cancer Res 5 (1999), 725–732.
6. Partridge, M., Brakenhoff, R., Phillips, E., et al. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin Cancer Res 9 (2003), 5287–5294.
7. Hristozova, T., Konschak, R., Stromberger, C., et al. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN). Ann Oncol 22 (2011), 1878–1885.
8. Tinhofer, I., Hristozova, T., Stromberger, C., et al. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 83 (2012), e685–e690.
9. Grobe, A., Blessmann, M., Hanken, H., et al. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity. Clin Cancer Res 20 (2014), 425–433.
10. Dreyer, J.H., Hauck, F., Oliveira-Silva, M., et al. Detection of HPV infection in head and neck squamous cell carcinoma: a practical proposal. Virchows Arch 462 (2013), 381–389.
11. Li, J., Shi, S.B., Shi, W.L., et al. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer. Transl Res 163 (2014), 27–35.
12. Larson, C.J., Moreno, J.G., Pienta, K.J., et al. Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A 62 (2004), 46–53.
13. Kallergi, G., Konstantinidis, G., Markomanolaki, H., et al. Apoptotic circulating tumor cells in early and metastatic breast cancer patients. Mol Cancer Ther 12 (2013), 1886–1895.
14. Ravichandran, K.S., Recruitment signals’ from apoptotic cells: invitation to a quiet meal. Cell 113 (2003), 817–820.
15. Kim, M.Y., Oskarsson, T., Acharyya, S., et al. Tumor self-seeding by circulating cancer cells. Cell 139 (2009), 1315–1326.
16. Xenidis, N., Ignatiadis, M., Apostolaki, S., et al. Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer. J Clin Oncol 27 (2009), 2177–2184.
17. Muller, V., Stahmann, N., Riethdorf, S., et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11 (2005), 3678–3685.
18. Georgoulias, V., Bozionelou, V., Agelaki, S., et al. Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study. Ann Oncol 23 (2012), 1744–1750.
19. Albers, A., Abe, K., Hunt, J., et al. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. Cancer Res 65 (2005), 11146–11155.
20. Nolz, J.C., Harty, J.T., Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection. Immunity 34 (2011), 781–793.
21. Formenti, S.C., Demaria, S., Systemic effects of local radiotherapy. Lancet Oncol 10 (2009), 718–726.